Despite reports of decreasing malaria burden across many parts of sub-Saharan Africa, the burden continues to be very high in Uganda. Indeed, the burden rose in two rural cohorts from 2011 to 2013. The use of long-lasting insecticidal nets (LLINs) and artemisinin-based combination therapies (ACTs) alone may be sufficient for minimizing the severity of disease, improving child health, and reducing childhood mortality. High-transmission countries like Uganda already bear a disproportionate burden of this disease and will likely require a more comprehensive suite of interventions to realize the successes now being celebrated in other parts of the world.
Moses Kamya is a Professor and Chair of the Department of Medicine at Makerere University College of Health Sciences. He has been conducting malaria and HIV research in Uganda for over 20 years with a particular focus on the interactions between HIV and malaria. He is the director of the Uganda Malaria Surveillance Project (UMSP). He is also the site principal investigator on the Program for Resistance, Immunology, Surveillance and Modeling (PRISM) of Malaria in Uganda and Project Leader of the surveillance component of PRISM.